Literature DB >> 18566424

Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node.

Joseph M Thompson1, Michael G Nicholson, Alan C Whitmore, Melodie Zamora, Ande West, Akiko Iwasaki, Herman F Staats, Robert E Johnston.   

Abstract

The strongest mucosal immune responses are induced following mucosal Ag delivery and processing in the mucosal lymphoid tissues, and much is known regarding the immunological parameters which regulate immune induction via this pathway. Recently, experimental systems have been identified in which mucosal immune responses are induced following nonmucosal Ag delivery. One such system, footpad delivery of Venezuelan equine encephalitis virus replicon particles (VRP), led to the local production of IgA Abs directed against both expressed and codelivered Ags at multiple mucosal surfaces in mice. In contrast to the mucosal delivery pathway, little is known regarding the lymphoid structures and immunological components that are responsible for mucosal immune induction following nonmucosal delivery. In this study, we have used footpad delivery of VRP to probe the constituents of this alternative pathway for mucosal immune induction. Following nonmucosal VRP delivery, J chain-containing, polymeric IgA Abs were detected in the peripheral draining lymph node (DLN), at a time before IgA detection at mucosal surfaces. Further analysis of the VRP DLN revealed up-regulated alpha4beta7 integrin expression on DLN B cells, expression of mucosal addressin cell adhesion molecule 1 on the DLN high endothelia venules, and production of IL-6 and CC chemokines, all characteristics of mucosal lymphoid tissues. Taken together, these results implicate the peripheral DLN as an integral component of an alternative pathway for mucosal immune induction. A further understanding of the critical immunological and viral components of this pathway may significantly improve both our knowledge of viral-induced immunity and the efficacy of viral-based vaccines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566424      PMCID: PMC3603373          DOI: 10.4049/jimmunol.181.1.574

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  Role of secretory antibodies in the defence against infections.

Authors:  Per Brandtzaeg
Journal:  Int J Med Microbiol       Date:  2003-04       Impact factor: 3.473

Review 2.  Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin.

Authors:  Gregory M Glenn; Richard T Kenney; Larry R Ellingsworth; Sarah A Frech; Scott A Hammond; J Paul Zoeteweij
Journal:  Expert Rev Vaccines       Date:  2003-04       Impact factor: 5.217

3.  Mucosal immunity induced by intramuscular administration of free peptides in-line with PADRE: IgA antibodies to the ELDKWA epitope of HIV gp41.

Authors:  N Decroix; C P Quan; P Pamonsinlapatham; J-P Bouvet
Journal:  Scand J Immunol       Date:  2002-07       Impact factor: 3.487

4.  CD11b+ Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells.

Authors:  Ayuko Sato; Masaaki Hashiguchi; Etsuko Toda; Akiko Iwasaki; Satoshi Hachimura; Shuichi Kaminogawa
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

5.  Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.

Authors:  G H MacDonald; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.

Authors:  Christian Peters; Xiaohui Peng; Dennis Douven; Zhen-Kun Pan; Yvonne Paterson
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

7.  Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells.

Authors:  J Rodrigo Mora; Maria Rosa Bono; N Manjunath; Wolfgang Weninger; Lois L Cavanagh; Mario Rosemblatt; Ulrich H Von Andrian
Journal:  Nature       Date:  2003-07-03       Impact factor: 49.962

8.  HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals.

Authors:  Luwy Musey; Yan Ding; Marnie Elizaga; Richard Ha; Connie Celum; M Juliana McElrath
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

Review 9.  IgA Fc receptors.

Authors:  Renato C Monteiro; Jan G J Van De Winkel
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant.

Authors:  Bengt Johansson-Lindbom; Marcus Svensson; Marc-André Wurbel; Bernard Malissen; Gabriel Márquez; William Agace
Journal:  J Exp Med       Date:  2003-09-08       Impact factor: 14.307

View more
  16 in total

1.  Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles.

Authors:  Daniel R Tonkin; Alan Whitmore; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2012-04-21       Impact factor: 3.641

Review 2.  Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells.

Authors:  J Rodrigo Mora; Ulrich H von Andrian
Journal:  Semin Immunol       Date:  2008-09-18       Impact factor: 11.130

3.  A mucosal adjuvant for the inactivated poliovirus vaccine.

Authors:  Benjamin P Steil; Patricia Jorquera; Janny Westdijk; Wilfried A M Bakker; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2013-12-13       Impact factor: 3.641

4.  Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization.

Authors:  Daniel R Tonkin; Patricia Jorquera; Tracie Todd; Clayton W Beard; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

Review 5.  Progress in respiratory virus vaccine development.

Authors:  Alexander C Schmidt
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

6.  Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques.

Authors:  Timothy D Carroll; Shannon R Matzinger; Mario Barro; Linda Fritts; Michael B McChesney; Christopher J Miller; Robert E Johnston
Journal:  Vaccine       Date:  2010-11-25       Impact factor: 3.641

7.  Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

Authors:  Anna D LoBue; Joseph M Thompson; Lisa Lindesmith; Robert E Johnston; Ralph S Baric
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice.

Authors:  M Jeff Bergen; Chien-Hsiung Pan; Catherine E Greer; Harold S Legg; John M Polo; Diane E Griffin
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

9.  Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.

Authors:  John T Bates; Jennifer A Pickens; Jennifer E Schuster; Monika Johnson; Sharon J Tollefson; John V Williams; Nancy L Davis; Robert E Johnston; Nancy Schultz-Darken; James C Slaughter; Frances Smith-House; James E Crowe
Journal:  Vaccine       Date:  2016-01-07       Impact factor: 3.641

10.  An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Authors:  Syed Muaz Khalil; Daniel R Tonkin; Andrew T Snead; Griffith D Parks; Robert E Johnston; Laura J White
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.